Veho, Jitsu and Gofo add capacity pre-holiday shipping rush
In their push to compete with FedEx and UPS, alternative carriers aim to gain business with more robust processing capabilities…
Keurig Dr Pepper eyes $200M in supply chain savings from spinoff
The beverage giant is carving out its coffee business, which will focus on sourcing resiliency, manufacturing consolidation and logistics optimization.
China temporarily halts export controls on rare earths, graphite, and other strategic materials
China’s Ministry of Commerce (MOFCOM) and the General Administration of Customs announced on November 7 that they will suspend the…
NJ Bio透過購置資產與整合L2P®服務彌合轉化研究鴻溝
美國紐澤西州普林斯頓市–(BUSINESS WIRE)–(美國商業資訊)– NJ Bio，股份有限公司，一家位於新澤西州普林斯頓的主要契约研究和臨床製造服務提供者，宣佈購買資產並全面整合L2P研究實驗室的研究服務® （“實驗室到藥房”），進一步擴大其服務組合，助力彌合轉化研究領域的鴻溝。 現時，通過1期臨床試驗的生物分子的磨損率非常高，克服這一挑戰的方法是通過轉化研究。 NJ Bio專注於臨床前和早期臨床研究和開發，主要關注ADC、生物偶聯、定制合成、寡核苷酸和mRNAs。 然而，公司此前在向客戶提供系統化轉化研究服務方面仍存在缺口。 通過資產購買和L2P服務的綜合，NJ Bio現在可以在一個傘下提供一套全面的臨床前和轉化研究服務，並將項目從概念驗證無縫地轉移到臨床。 這種方法支持更智慧的數據驅動決策，加快開發進度，改善臨床結果，為客戶的1期及以後項目提供更好的成功機會。 L2P研究實驗室® 其綜合臨床前研發支持，特別是在腫瘤學研究和支持IND應用的服務方面，得到了廣泛認可。 隨著這些服務綜合到NJ Bio的產品中，L2P研究實驗室® , 已停止獨立運營，其臨床前和轉化研究服務組
Nvidia faces Washington heat over alleged Huawei ties
US lawmakers are ramping up scrutiny of China’s AI and semiconductor sectors, tightening oversight from corporate ties to capital flows…
Advanced packaging emerges as AI’s next performance frontier, insights from DIGITIMES analyst Tony Huang
As Moore’s Law slows, advanced packaging has become the critical lever driving breakthroughs in AI chip performance, according to DIGITIMES…
Twoway Communications reports strong revenue and outlines growth strategy under new COO
Twoway Communications announced on November 5 that its unaudited consolidated revenue for the third quarter of 2025 reached NT$353 million…
Novatek braces for revenue dip in 2025, bets on AI ASICs to drive recovery
Novatek Microelectronics, Taiwan’s top display driver IC (DDI) supplier, held its earnings call with CEO Steve Wang outlining the company’s…
Elon Musk maps out Tesla’s semiconductor leap, ponders alliance with Intel
Tesla CEO Elon Musk said the company is considering building a large semiconductor fabrication plant to meet rising demand for…